Select Location
What is your delivery location?
We need your delivery location to continue browsing
Select Location
We need your delivery location to continue browsing
Prescription Required
Arechar HealthCare
120 Tablets in Bottle
Abiraterone Acetate
Keep in cold place
Delivering To:
Overview
Abiraterone Acetate 250mg tablet belongs to a class of medication known as androgen biosynthesis inhibitors. It is used in the treatment of men diagnosed with prostate cancer. This tablet works by blocking the activity of an enzyme (CYP17) that is responsible for the production of the androgen (male hormone), resulting in slowing down the multiplication of cancer cells.
Prostate Cancer
Side effects are undesirable symptoms that can result from any medical treatment. Like any other medicine, Abiraterone Acetate 250mg tablet also causes some adverse impact on the body, most of which resolve without any medical attention. Some common side effects include: Anemia
Increased levels of blood fat
Confusion
Sweating
Irritability
Cough
Joint pain
Nausea
Headache
Swelling
High cholesterol
Fast heartbeat
Diarrhea
High blood pressure
Fever
Hypersensitivity
Dizziness
Muscle pain
Seek medical attention immediately in case of any unusual or persistent side effects.
The dosage and duration of the Abiracine tablet are decided by the doctor based on the stage of cancer and other health factors. Eat the medicine on an empty stomach for better results. Before starting this tablet, please inform your doctor about your medical history. If you experience any signs and symptoms while eating this medication that are not manageable, do not ignore those symptoms because they may lead to a higher risk.
Alcohol
unsafe
Avoid the consumption of alcohol while taking Abiraterone Acetate 250mg tablet, as alcohol can reduce the effectiveness of the medicine and worsen the symptoms
Pregnancy
risky
Abiraterone Acetate 250mg tablet is not recommended during pregnancy as it is unsafe for the developing fetus. Doctors rarely prescribe this medicine in pregnancy.
Breast Feeding
risky
Abiraterone Acetate 250mg tablet is unsafe to use during breastfeeding as it may cause toxicity to the baby.
Driving
danger
Azacitidine 100mg Injection may cause side effects such as dizziness or lack of concentration, which could affect your ability to drive. So it's better to avoid driving or operating heavy machinery.
Kidney
caution
Consumption of Abiracine should be avoided without informing the doctor if you have any kidney-related issues.
Liver
caution
Consumption of Abiraterone Acetate 250mg tablet should be avoided without informing the doctor if you have any liver-related issues.
Do not skip the dose of Abiracine tablets. Consult the doctor immediately in case of missed or overdose.
Abiracine tablet is used in the treatment of prostate cancer. It belongs to a class of medication known as androgen biosynthesis inhibitors. Abiracine tablet helps to slow down the multiplication of cancer cells and kill them.
Abiracine is an anti-cancer medication, and it works by blocking the activity of an enzyme (CYP17) that is responsible for the production of the male hormone androgen.
Avoid driving as Abiracine tablets may decrease your ability to drive or affect your vision.
Consult your doctor in case of liver disease before consuming Abiraterone Acetate 250mg tablet.
This medication is not recommended during pregnancy
1. https://medlineplus.gov/druginfo/meds/a611046.html
2. https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=f308b463-27e4-422a-95a2-ecbbf95eee20
3. Goldwater, R., Hussaini, A., Bosch, B., & Nemeth, P. (2017). Comparison of a novel formulation of abiraterone acetate vs. the originator formulation in healthy male subjects: two randomized, open-label, crossover studies. Clinical Pharmacokinetics, 56(7), 803-813.
4. Hoy, S. M. (2013). Abiraterone acetate: a review of its use in patients with metastatic castration-resistant prostate cancer. Drugs, 73(18), 2077-2091.
Arechar HealthCare
Written By
Venika Choudhary
Medical Content Writer @ Magicine Pharma
I hold an M.Sc. in Microbiology and have a strong academic foundation in microbial sciences and applied biotechnology. I began my career with extensive hands-on research at CSIR laboratories, focusing on fungal enzyme production, studying fungal diversity in various ecosystems, and developing bio-pesticides as sustainable alternatives to chemical pesticides. This work deepened my understanding of fungal biology, bioactive compounds, and their pharmaceutical and agricultural applications. Transitioning from research, I now work as a medical content writer, where I combine my scientific expertise with a passion for clear and reliable healthcare communication. I apply my research background to create patient-friendly, compliant content for pharmaceutical companies and healthcare platforms, ensuring science is both trustworthy and accessible. Specializing in clear, accurate, and engaging content, I help patients make informed decisions and support pharmaceutical companies in delivering trusted information. Whether writing product descriptions, crafting disease awareness articles, or composing drug information leaflets, I consistently meet regulatory standards and address audience needs, making my content an asset for healthcare brands.
Reviewed By
Dr. Aditya Sarin - MBBS, MD, DrNB - Consultant Medical Oncology
Dr. Aditya Sarin, MBBS, MD, DrNB, is a highly qualified medical oncologist with profound research and clinical expertise, currently working at Sir Ganga Ram Hospital, New Delhi. He is also a member of the European Society of Medical Oncology (ESMO), a non-profit European organization dedicated to eradicating cancer by promoting comprehensive cancer care and advancing medical oncology. He has been honored with several awards, including the International Cancer Foundation scholarship (ESMO congress, 2022) and Young Medical Oncologist of the Year (Times of India, 2024). He is well-known for his breakthrough in oncology. Dr. Sarin is passionate about converting complex health information into a concise and clear form that is understandable to everyone, aiming to create awareness and cancer care among people.